We are live on ! Find out more
AKYA

Akoya BioSciences
AKYA

Delisted

AKYA was delisted on the 7th of July, 2025.

Back to rankings

60 hedge funds and large institutions have $189M invested in Akoya BioSciences in 2021 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27.12% more ownership

Funds ownership: 0% → 27.12% (+27%)

Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
+$46.3M
2
HEC
Hudson Executive Capital
New York
+$22.1M
3
Capital World Investors
Capital World Investors
California
+$14.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.3M
5
BlackRock
BlackRock
New York
+$9.12M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$1.25M +$1.34M +64,872 New
Charles Schwab
27
Charles Schwab
California
$978K +$1.04M +50,522 New
CCM
28
CAAS Capital Management
New York
$977K +$1.04M +50,500 New
Blackstone Inc
29
Blackstone Inc
New York
$967K +$1.03M +50,000 New
Alyeska Investment Group
30
Alyeska Investment Group
Illinois
$906K +$967K +46,825 New
Citadel Advisors
31
Citadel Advisors
Florida
$883K +$943K +45,661 New
Ameriprise
32
Ameriprise
Minnesota
$808K +$863K +41,792 New
MIM
33
Monashee Investment Management
Massachusetts
$736K +$786K +38,064 New
Marshall Wace
34
Marshall Wace
United Kingdom
$471K +$503K +24,357 New
GCM
35
Ghisallo Capital Management
Massachusetts
$387K +$413K +20,000 New
ZP
36
Zimmer Partners
New York
$387K +$413K +20,000 New
Tudor Investment Corp
37
Tudor Investment Corp
Connecticut
$279K +$298K +14,444 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$277K +$295K +14,309 New
SG Americas Securities
39
SG Americas Securities
New York
$266K +$284K +13,756 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$256K +$273K +13,238 New
Walleye Trading
41
Walleye Trading
New York
$248K +$264K +12,798 New
N
42
Nuveen
North Carolina
$234K +$250K +12,101 New
Federated Hermes
43
Federated Hermes
Pennsylvania
$232K +$248K +12,000 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$203K +$217K +10,512 New
JP Morgan Chase
45
JP Morgan Chase
New York
$193K +$205K +9,941 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$126K +$134K +6,500 New
Bank of America
47
Bank of America
North Carolina
$93K +$99.4K +4,814 New
Deutsche Bank
48
Deutsche Bank
Germany
$88K +$93.6K +4,534 New
TRCT
49
Tower Research Capital (TRC)
New York
$54K +$57.8K +2,798 New
SO
50
STRS Ohio
Ohio
$34K +$37.2K +1,800 New
1
2
3

AKYA Hedge Fund Activity: Q2 2021 in Review

60 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q2 2021, worth a combined $189M.

Buyers outnumbered sellers: 60 funds opened new AKYA positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Board of Trustees of The Leland Stanford Junior University, opening a new position worth an estimated $46.3M.

  • 60 institutional investors held Akoya BioSciences (AKYA) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $189M of Akoya BioSciences stock for Q2 2021.
  • 60 funds opened new Akoya BioSciences positions in Q2 2021 and 0 closed out, a net change of +60 holders.
  • The largest Akoya BioSciences buyer in Q2 2021 was Board of Trustees of The Leland Stanford Junior University, an estimated $46.3M added.

Based on aggregated 13F filings for Q2 2021.